ADAMTS5
ADAM metallopeptidase with thrombospondin type 1 motif, 5 (aggrecanase-2) | |
---|---|
Identifiers | |
Symbol | ADAMTS5 |
Entrez | 11096 |
HUGO | 221 |
OMIM | 605007 |
RefSeq | NM_007038 |
UniProt | Q9UNA0 |
Other data | |
Locus | Chr. 21 q22.1-q22 |
WikiDoc Resources for ADAMTS5 |
Articles |
---|
Most recent articles on ADAMTS5 |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on ADAMTS5 at Clinical Trials.gov Clinical Trials on ADAMTS5 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on ADAMTS5
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating ADAMTS5 Risk calculators and risk factors for ADAMTS5
|
Healthcare Provider Resources |
Causes & Risk Factors for ADAMTS5 |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
ADAMTS5 (aggrecanase) is an enzyme that destroys cartilage in mice. Its discovery may lead to progress in human arthritis research. This enzyme may also be involved in cartilage deterioration in humans. It has been isolated and identified by Australian scientists in Sydney. ADAMTS5 has been indicated as being important in early osteoarthritis.
External links